ReviewRSC advances2026
Sustainable synthesis of mono-, bi- and tri-metallic nanoparticles using endophytic fungi: characterization and different applications.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endophytic fungi represent an emerging and promising biological platform for the sustainable biosynthesis of nanoparticles within the rapidly developing field of green nanotechnology. Conventional physicochemical methods for nanoparticle production often require toxic chemicals, high energy consumption, and complex processing conditions, which raise environmental and biomedical safety concerns. In contrast, fungal endophyte-mediated synthesis provides an eco-friendly, cost-effective, and scalable alternative for generating metal and metal oxide nanoparticles. Endophytic fungi inhabit internal plant tissues without causing disease and possess diverse metabolic pathways capable of reducing metal ions into stable nanoparticles through enzymatic and biochemical processes. Various biomolecules produced by these fungi, including reductases, proteins, phenolics, flavonoids, and other secondary metabolites, act simultaneously as reducing and stabilizing agents during nanoparticle formation. As a result, nanoparticles synthesized
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.